Drugs that contain Risperidone

1. List of Perseris Kit drug patents

PERSERIS KIT's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10406160 INDIVIOR INC Sustained release small molecule drug formulation
Jun, 2026

(3 years from now)

US10058554 INDIVIOR INC Sustained release small molecule drug formulation
Sep, 2026

(3 years from now)

US9597402 INDIVIOR INC Sustained release small molecule drug formulation
Sep, 2026

(3 years from now)

US11110093 INDIVIOR INC Sustained release small molecule drug formulation
Nov, 2026

(3 years from now)

US10010612 INDIVIOR INC Sustained delivery formulations of risperidone compounds
Feb, 2028

(4 years from now)

US9180197 INDIVIOR INC Sustained delivery formulations of risperidone compounds
Feb, 2028

(4 years from now)

US9186413 INDIVIOR INC Sustained delivery formulations of risperidone compounds
Feb, 2028

(4 years from now)

US10376590 INDIVIOR INC Sustained delivery formulations of risperidone compound
Feb, 2028

(4 years from now)

US11013809 INDIVIOR INC Sustained delivery formulations of risperidone compound
Feb, 2028

(4 years from now)

Market Authorisation Date: 27 July, 2018

Treatment: Method of treating schizophrenia; Administration of risperidone; Treating schizophrenia; Treatment of schizophrenia

Dosage: FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS

More Information on Dosage

PERSERIS KIT family patents

17

United States

6

Japan

4

European Union

3

Spain

2

Denmark

2

Canada

2

Mexico

2

Australia

2

New Zealand

2

China

1

Israel

1

Hong Kong

1

Argentina

1

Brazil

1

Poland

1

Austria

1

Taiwan, Province of China

2. List of Rykindo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10406161 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(9 years from now)

US10098882 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(9 years from now)

US9532991 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(9 years from now)

US9446135 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(9 years from now)

US11110094 SHANDONG LUYE Risperidone sustained release microsphere composition
Apr, 2032

(9 years from now)

Market Authorisation Date: 13 January, 2023

Treatment: Treatment of schizophrenia in adults

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in